Who Exports Chloroquine from India — 287 Suppliers Behind a $171.3M Market
India's chloroquine export market is supplied by 287 active exporters who collectively shipped $171.3M across 5,437 shipments. ZYDUS LIFESCIENCES LIMITED leads with a 68.2% market share, followed by IPCA LABORATORIES LIMITED and CADILA HEALTHCARE LIMITED. The top 5 suppliers together control 93.8% of total export value, reflecting a concentrated market structure.
Top Chloroquine Exporters from India — Ranked by Export Value
ZYDUS LIFESCIENCES LIMITED is the leading chloroquine exporter from India, holding a 68.2% share of the $171.3M market across 5,437 shipments from 287 exporters. The top 5 suppliers — ZYDUS LIFESCIENCES LIMITED, IPCA LABORATORIES LIMITED, CADILA HEALTHCARE LIMITED, CADILA HEALTHCARE LTD, INTAS PHARMACEUTICALS LIMITED — collectively control 93.8% of total export value, indicating a highly concentrated market. Individual shares are: ZYDUS LIFESCIENCES LIMITED (68.2%), IPCA LABORATORIES LIMITED (19.0%), CADILA HEALTHCARE LIMITED (4.0%), CADILA HEALTHCARE LTD (1.6%), INTAS PHARMACEUTICALS LIMITED (1.0%).
Top Chloroquine Exporters from India
Ranked by export value · 287 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | ZYDUS LIFESCIENCES LIMITED HYDROXYCHLOROQUINE SULFATE TABLETS USP 200MGPHARMA : HYDROXYCHLOROQUINE SULFATE TABLHYDROXYCHLOROQUINE SULFATE TABLETS USP 200MGTBS | $116.8M | 8 | 68.2% |
| 2 | IPCA LABORATORIES LIMITED HCQS 200MG TABLETSHYDROXYCHLOROQUINE SULFATE TABLETS USP 200MGPHARMA : HYDROXYCHLOROQUINE SULFATE TABL | $32.6M | 34 | 19.0% |
| 3 | CADILA HEALTHCARE LIMITED HYDROXYCHLOROQUINE SULFATE TABLETS USP 200MGPHARMA : HYDROXYCHLOROQUINE SULFATE TABLHYDROXYCHLOROQUINE SULFATE TABLETS USP 200MGTBS | $6.8M | 5 | 4.0% |
| 4 | CADILA HEALTHCARE LTD HYDROXYCHLOROQUINE SULFATE TABLETS USP 200MGPHARMA : HYDROXYCHLOROQUINE SULFATE TABLHYDROXYCHLOROQUINE SULFATE TABLETS USP 200MGTBS | $2.8M | 4 | 1.6% |
| 5 | INTAS PHARMACEUTICALS LIMITED HYDROXYCHLOROQUINE SULFATE TABLETS USP 200MGPHARMA : HYDROXYCHLOROQUINE SULFATE TABLDROLSAN 200MG TABLETS | $1.8M | 3 | 1.0% |
| 6 | SUN PHARMACEUTICAL INDUSTRIES LIMITED HYDROQUIN TABLETS (ZYQUENIL HYDROXYCHLOROQUINE SULFATE TABZYQUENIL 10X10 T | $1.3M | 1 | 0.7% |
| 7 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED HYDROXYCHLOROQUINE SULFATE TABLETS USP 200MGPHARMA : HYDROXYCHLOROQUINE SULFATE TABLHYDROXYCHLOROQUINE SULFATE TABLETS USP 200MGTBS | $1.1M | 2 | 0.6% |
| 8 | NITIN LIFESCIENCES LIMITED ESSENTIAL PHARMACEUTICALS. CHLOROQUINE PHOSPHATE INJECTION | $854.3K | 1 | 0.5% |
| 9 | SYNCOM FORMULATIONS (INDIA) LIMITED ESSENTIAL PHARMACEUTICALS. CHLOROQUINE PHOSPHATE INJECTION | $713.0K | 7 | 0.4% |
| 10 | CARITAS HEALTHCARE PRIVATE LIMITED | $523.4K | 1 | 0.3% |
| 11 | LABORATE PHARMACEUTICALS INDIA LTD ESSENTIAL PHARMACEUTICALS. CHLOROQUINE PHOSPHATE INJECTION | $521.3K | 2 | 0.3% |
| 12 | MAPLE CROSS REMEDIES PRIVATE LIMITED ESSENTIAL PHARMACEUTICALS. CHLOROQUINE PHOSPHATE INJECTION | $270.8K | 1 | 0.2% |
| 13 | MEDOPHARM HYDROXYCHLOROQUINE SULFATE TABLETS USP 200MGPHARMA : HYDROXYCHLOROQUINE SULFATE TABLHYDROXYCHLOROQUINE SULFATE TABLETS USP 200MGTBS | $269.4K | 7 | 0.2% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Chloroquine exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Zydus Lifesciences Limited | Warning Letter issued Aug | Yes, certified April | Yes | Not verified | FDA Warning Letter in August 2024; compliance achieved by December 2025. |
| Intas Pharmaceuticals Limited | Not Listed | Yes | Yes | Not verified | EU GMP certified in April 2007; WHO GMP status confirmed. |
| Cadila Pharmaceuticals Limited | Not Listed | Yes | Not Listed | Not verified | WHO GMP compliant facility in Ethiopia; FDA Warning Letter in 2014 for Ankleshwa |
TransData Nexus reviewed the regulatory standing of 3 leading Chloroquine exporters from India. 0 hold US FDA facility approvals, 3 maintain WHO-GMP certification, and 2 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Chloroquine sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is renowned for its extensive production of active pharmaceutical ingredients (APIs). The city hosts numerous API manufacturing facilities, contributing significantly to the global supply chain. Companies like Granules India Limited, headquartered in Hyderabad, are instrumental in producing APIs for various medications. Granules India is involved in the manufacture and sale of APIs, pharmaceutical formulation intermediates, and finished dosage forms, including products such as Paracetamol, Metformin, and Guaifenesin.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is a prominent hub for pharmaceutical formulations. This region is home to major companies like Zydus Lifesciences Limited (formerly Cadila Healthcare Limited) and Intas Pharmaceuticals. Zydus Lifesciences, headquartered in Ahmedabad, is a leading manufacturer of generic drugs and has a significant presence in the global pharmaceutical market. Intas Pharmaceuticals, also based in Ahmedabad, specializes in generic therapeutic drugs and has a strong international footprint. These companies are key players in the production and export of pharmaceutical formulations, including Chloroquine.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a crucial export gateway for India's pharmaceutical products. This region's proximity to major ports facilitates efficient international distribution. Companies like Sun Pharmaceutical Industries Limited, headquartered in Mumbai, leverage this strategic location to export a wide range of pharmaceutical products globally. Sun Pharma is one of the largest pharmaceutical companies in India, with a diverse portfolio that includes generic and specialty medicines.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh is known for its favorable tax incentives, attracting numerous pharmaceutical manufacturers. This region has become a significant center for pharmaceutical production, with companies establishing manufacturing units to benefit from the tax advantages and contribute to the domestic and international supply of medications.
5Sourcing Recommendations
- Diversify Supplier Base: To mitigate risks associated with supply chain disruptions, consider sourcing Chloroquine from multiple manufacturers across different pharmaceutical clusters in India.
- Evaluate Manufacturing Capabilities: Assess the production capacities and quality standards of potential suppliers, focusing on those with a proven track record in API and formulation manufacturing.
- Leverage Export Hubs: Utilize suppliers located in export-centric regions like the Mumbai-Thane-Raigad belt to ensure efficient logistics and timely delivery of Chloroquine shipments.
- Monitor Regulatory Compliance: Ensure that selected suppliers adhere to international regulatory standards and have the necessary certifications from authorities such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA).
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Chloroquine exporters from India
Zydus Lifesciences Limited — Zydus acquires majority stake in Amplitude Surgical SA
Zydus Lifesciences entered into exclusive negotiations to acquire an 85.6% stake in France-based Amplitude Surgical SA, a leading medical technology company specializing in lower-limb orthopedic solutions. - IMPACT: This acquisition is not expected to directly impact chloroquine exports.
Impact: This acquisition is not expected to directly impact chloroquine exports.
Zydus Lifesciences Limited — Zydus acquires Agenus' CDMO business
Zydus Lifesciences acquired the Contract Development and Manufacturing Organization (CDMO) business of Agenus, including two biologics manufacturing sites in Emeryville and Berkeley. Additionally, Zydus partnered with Agenus to commercialize their molecules in India. - IMPACT: This acquisition is not expected to directly impact chloroquine exports.
Impact: This acquisition is not expected to directly impact chloroquine exports.
Zydus Lifesciences Limited — Zydus plans Rs 5,000-crore QIP for M&A opportunities
Zydus Lifesciences appointed three investment banks to advise on a fund-raise of up to Rs 5,000 crore via the qualified institutional placement (QIP) route. The firm aims to reduce debt and pursue M&A opportunities, particularly related to its US specialty business. - IMPACT: This initiative may indirectly influence chloroquine exports by enhancing the company's overall financial position and capacity.
Impact: This initiative may indirectly influence chloroquine exports by enhancing the company's overall financial position and capacity.
Common Questions — Chloroquine Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which chloroquine supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, ZYDUS LIFESCIENCES LIMITED leads with 260 recorded shipments worth $116.8M. IPCA LABORATORIES LIMITED (382 shipments) and CADILA HEALTHCARE LIMITED (41 shipments) are also established high-volume exporters.
Q How many chloroquine manufacturers are there in India?
India has 287 active chloroquine exporters with a combined export market of $171.3M across 5,437 shipments to 120 countries. The top 5 suppliers hold 93.8% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for chloroquine from India?
Average FOB unit price: $5.97 per unit, ranging from $0.00 to $3581.74. Average shipment value: $31.5K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 287 verified Indian exporters of Chloroquine ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 5,437 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 120 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
5,437 Verified Shipments
287 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists